Hbk Investments L P Zoetis Inc. Transaction History

Hbk Investments L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $7.16 Million - $8.17 Million	-63,647 Reduced 96.37%	2,399 $299,000
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $9.81 Million - $11.8 Million	-123,706 Reduced 65.19%	66,046 $5.65 Million
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $4.15 Million - $4.64 Million	49,752 Added 35.54%	189,752 $17.4 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $902,470 - $1.01 Million	-11,295 Reduced 7.47%	140,000 $11.9 Million
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $2.86 Million - $3.38 Million	-39,959 Reduced 20.89%	151,295 $12.6 Million
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $9.72 Million - $11.2 Million	-153,657 Reduced 44.55%	191,254 $13.8 Million
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $20.6 Million - $22.6 Million	344,911	344,911 $22 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.